umbilical cord-derived mesenchymal stem cells (Beijing Health & Biotech Stem Cell Institute )

N/A

Report date: 2025/01/26 16:42:28

Base Information

Drug Nameumbilical cord-derived mesenchymal stem cells (Beijing Health & Biotech Stem Cell Institute )
Drug Alias Nameumbilical cord-derived mesenchymal stem cells (Beijing Health & Biotech Stem Cell)UC-MSCs (Beijing Health & Biotech Stem Cell Institute)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Health&Biotech Group Corp Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Health&Biotech Group Corp Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A